These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 24733560)

  • 1. Immune escape of γ-herpesviruses from adaptive immunity.
    Hu Z; Usherwood EJ
    Rev Med Virol; 2014 Nov; 24(6):365-78. PubMed ID: 24733560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune mechanisms in murine gammaherpesvirus-68 infection.
    Stevenson PG; Efstathiou S
    Viral Immunol; 2005; 18(3):445-56. PubMed ID: 16212523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects of a novel vaccination strategy for human gamma-herpesviruses.
    Wu TT; Blackman MA; Sun R
    Immunol Res; 2010 Dec; 48(1-3):122-46. PubMed ID: 20717741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses.
    Feng P; Moses A; Früh K
    Curr Opin Virol; 2013 Jun; 3(3):285-95. PubMed ID: 23735334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A replication-deficient murine gamma-herpesvirus blocked in late viral gene expression can establish latency and elicit protective cellular immunity.
    Kayhan B; Yager EJ; Lanzer K; Cookenham T; Jia Q; Wu TT; Woodland DL; Sun R; Blackman MA
    J Immunol; 2007 Dec; 179(12):8392-402. PubMed ID: 18056385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine herpesvirus pathogenesis: a model for the analysis of molecular mechanisms of human gamma herpesvirus infections.
    Rajćáni J; Kúdelová M
    Acta Microbiol Immunol Hung; 2005; 52(1):41-71. PubMed ID: 15957234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early establishment of gamma-herpesvirus latency: implications for immune control.
    Flaño E; Jia Q; Moore J; Woodland DL; Sun R; Blackman MA
    J Immunol; 2005 Apr; 174(8):4972-8. PubMed ID: 15814726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology Frontiers in γ-Herpesviruses Treatments.
    Granato M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses.
    Früh K; Bartee E; Gouveia K; Mansouri M
    Virus Res; 2002 Sep; 88(1-2):55-69. PubMed ID: 12297327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection.
    Virgin HW; Speck SH
    Curr Opin Immunol; 1999 Aug; 11(4):371-9. PubMed ID: 10448140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of angelicin against gammaherpesviruses.
    Cho HJ; Jeong SG; Park JE; Han JA; Kang HR; Lee D; Song MJ
    Antiviral Res; 2013 Oct; 100(1):75-83. PubMed ID: 23892155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells.
    Tibbetts SA; Suarez F; Steed AL; Simmons JA; Virgin HW
    Virology; 2006 Sep; 353(1):210-9. PubMed ID: 16797052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γ-Herpesvirus reactivation differentially stimulates epitope-specific CD8 T cell responses.
    Freeman ML; Burkum CE; Jensen MK; Woodland DL; Blackman MA
    J Immunol; 2012 Apr; 188(8):3812-9. PubMed ID: 22407914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma herpesviruses: pathogenesis of infection and cell signaling.
    Rajcáni J; Kúdelová M
    Folia Microbiol (Praha); 2003; 48(3):291-318. PubMed ID: 12879740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Dendritic Cells in Immune Control and Vaccination against -Herpesviruses.
    Münz C
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31817510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting the host response to a gamma-herpesvirus.
    Doherty PC; Christensen JP; Belz GT; Stevenson PG; Sangster MY
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):581-93. PubMed ID: 11313013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncogenic gamma herpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) hijack retinoic acid-inducible gene I (RIG-I) facilitating both viral and tumour immune evasion.
    Nash A; Ryan EJ
    Tumour Virus Res; 2022 Dec; 14():200246. PubMed ID: 35998812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.
    Wei F; Zhu Q; Ding L; Liang Q; Cai Q
    Virol Sin; 2016 Oct; 31(5):395-405. PubMed ID: 27624182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune evasion by gamma-herpesviruses.
    Stevenson PG
    Curr Opin Immunol; 2004 Aug; 16(4):456-62. PubMed ID: 15245739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.